Management options for established chemotherapy-induced peripheral neuropathy
10.1007/s00520-014-2289-x
Saved in:
Main Authors: | Pachman, D.R., Watson, J.C., Lustberg, M.B., Wagner-Johnston, N.D., Chan, A., Broadfield, L., Cheung, Y.T., Steer, C., Storey, D.J., Chandwani, K.D., Paice, J., Jean-Pierre, P., Oh, J., Kamath, J., Fallon, M., Strik, H., Koeppen, S., Loprinzi, C.L. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/125026 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy
by: Leen, AJ, et al.
Published: (2022) -
Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
by: Jia, J, et al.
Published: (2022) -
Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
by: Cheng, H.L., et al.
Published: (2021) -
Management of treatment-emergent peripheral neuropathy in multiple myeloma
by: Richardson, P.G., et al.
Published: (2016) -
Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
by: Molassiotis, A., et al.
Published: (2021)